AIM ImmunoTech Inc. (AIM) insider trading.
In Q3 2026, insiders at AIM ImmunoTech Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 4 open-market purchases worth $13K and 0 sales.
- Transactions
- 4
- Purchases (P)
- 4
- Sales (S)
- 0
- Net shares, P minus S
- 62,900
- Insiders
- 1
- Last filed
- 2026-09-18
Insiders
| Insider | Relationship | Transactions | Buys | Sales |
|---|---|---|---|---|
| Equels Thomas K | Director, Officer · CEO & President | 4 | 4 | 0 |
Transactions
| Date | Insider | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-17 | Equels Thomas K | P (A) | 24,000 | $0.21 | 126,822 | Form 4 |
| 2026-09-16 | Equels Thomas K | P (A) | 11,000 | $0.21 | 102,822 | Form 4 |
| 2026-09-15 | Equels Thomas K | P (A) | 22,000 | $0.22 | 91,822 | Form 4 |
| 2026-09-14 | Equels Thomas K | P (A) | 5,900 | $0.22 | 69,822 | Form 4 |
Transaction codes in this quarter
Get AIM insider transactions through the API
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=946644&limit=100" \
-H "Authorization: Bearer $SEC_API_KEY"Insider trading API guide · AIM company page · AIM ImmunoTech Inc. on SEC.gov
Questions
Are insiders buying or selling AIM ImmunoTech Inc. (AIM)?
In Q3 2026, insiders at AIM ImmunoTech Inc. reported 4 non-derivative transactions on 4 Forms 3, 4 and 5: 4 open-market purchases worth $13K and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.
Where do these AIM ImmunoTech Inc. insider trades come from?
From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.
Plain-text version for agents and LLMs: /insider-trading/aim.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.